Recombinant WT assemblies were produced following the protocol described previously33. Briefly, HIV-1 WT Gag was expressed in E. coli and purified by ion-exchange chromatography. In vitro assembly was done by mixing 4 mg/ml of protein with yeast transfer RNA overnight. PR digestion experiments with recombinant WT and T8I assemblies were performed by the addition of various concentrations of PR to the Gag WT assembly mixture and T8I cell lysate which was pre-treated and diluted to 2 mg/ml, and incubated at 37 °C for 2 h. For kinetic analysis of Gag WT and T8I cleavage, 3.3 μM of HIV-1 PR was added to the Gag assembly mixture and incubated at 37 °C, at different time points, 4ul of the digestion reaction mixture was taken out and mixed with NuPAGE® LDS Sample Buffer (Invitrogen) to stop the reaction, and then subjected to NuPAGE Novex 4–12% Bis-Tris gel (Invitrogen) for cleavage products analysis and visualized by Coomassie blue staining.
Copyright and License information: The Author(s) ©2021
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Note: The content above has been extracted from a research article, so it may not display correctly.